Abstract
This Health Industry Insights Perspective contains the complete transcript of
the October 12, 2005, Life Science Insights/Bio-IT World-sponsored systems
biology modeling roundtable, which brought together key thought leaders to
better understand the fundamental knowledge-based modeling needs of the
pharmaceutical industry, leading modeling solution vendors, and academic
researchers. In looking to clear the air between real and perceived
pharmaceutical industry needs, differentiate the modeling solution
opportunities, and discuss emerging academic thinking, the forum allowed for
interaction that was enlightening for all involved.
"The implementation of knowledge-based drug development is enabled by modeling.
As a direct application of systems biology approaches, the pharmaceutical
industry can achieve both time and monetary savings by leveraging
knowledge-based modeling in the drug development process," said Alan Louie,
Ph.D., research director responsible for Health Industry Insights' research on
technology solutions for drug discovery.
Roundtable held October 12, 2005, in Boston
View Cart
